LHCVX Mutual Fund

LHCVX Mutual Fund

NAV$24.85
See how much of LHCVX you already own
Just $25 once·$69/mo·Download sample
X-ray my portfolio free

Fund Essentials - as of Apr 30, 2026

Net Assets
-
Expense Ratio
0.68%
Dividend Yield (Current)
0.36%
Holdings
64
Inception Date
Jul 31, 2019
Fund Family
Lord Abbett Family of Funds
Investment Style
PRO
Asset Class
PRO
Legal Structure
PRO
Dividend Frequency
Annually

Performance

YTD+3.46%
1 Year+29.05%
3 Year+9.41%
5 Year+3.95%

Asset Allocation

Stocks: 96.38%
Cash: 1.69%
Other: 1.93%
See how much of LHCVX you already own
Your funds unpacked, overlap, fees and score, free on screen. The full report is $25, once. Download sample.
X-ray my portfolio free

Top Holdings

View All →
TickerNameWeight
LLYEli Lilly & Co.8.89%
AZN:LNAstraZeneca PLC4.73%
GILDGilead Sciences4.25%
JNJJohnson & Johnson - Common3.19%
NKTRNektar Therapeutics3.17%
Top 10 Concentration: 37.55%Report Date: Apr 30, 2026
Download all 64 holdings for LHCVX
CSV export with sector, industry & share changes
Get CSV

Dividend Summary

View Details →
Dividend Yield (Current)
0.36%
Frequency
Annually
Latest Distribution
$1.47
-

Peer Comparison

Benchmark
PRO
Peer outperformance: PRO
Category rank: PRO
This Mutual Fund
PRO
Peer Avg
PRO

LHCVX Mutual Fund Overview

LHCVX Mutual Fund (Lord Abbett Health Care Fund Class R6) is managed by Lord Abbett Family of Funds. LHCVX expense ratio is 0.68%, holding 64 positions across sectors including Health Care, Financials, Industrials. Inception date: 2019-07-31.

LHCVX performance shows a YTD return of 3.46%. The 1-year return is 29.05% and the 5-year return is 3.95%. LHCVX dividend yield stands at 0.36%, paid annually.

LHCVX top holdings include Eli Lilly & Co. (8.9%), AstraZeneca PLC (4.7%), Gilead Sciences (4.3%), Johnson & Johnson - Common (3.2%), Nektar Therapeutics (3.2%). Go to all LHCVX holdings, LHCVX sectors, or LHCVX dividends.

LHCVX can be compared against other funds. Use LHCVX overlap to find shared positions, or LHCVX vs another fund for a side-by-side view. LHCVX alternatives are available via the screener, along with tax-loss harvesting opportunities.